ROBERT W. SWEET, District Judge.
Defendants GlaxoSmithKline, LLC, doing business as GSK ("GSK") and GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (together with GSK, the "Defendants") have moved pursuant to Federal Rule of Civil Procedure 56 to dismiss the complaint of Plaintiff April Dearden ("Dearden" or the "Plaintiff") for her retaliation and discrimination claims under the Family and Medical Leave Act ("FMLA") and New York Human Rights Law ("NYSHRL") (the "Amended Complaint," Dkt. No. 26). Based upon the facts and conclusions set forth below, the Defendants' motion for summary judgment is granted, and the Amended Complaint is dismissed.
Plaintiff filed her Complaint on September 28, 2015, and, pursuant to a stipulation between the parties, filed an Amended Complaint on September 24, 2016. (
On April 14, 2017, Defendants moved for summary judgment. (Dkt. No. 30.) The instant motion was heard and marked fully submitted on June 21, 2017.
The facts have been set forth in Defendants' Statement of Undisputed Material Facts, (Dkt. No. 32), and Plaintiff's Rule 56.1 Counter-Statement in Opposition, (Dkt. No. 37). The facts are not in dispute except as noted below.
GSK is a global pharmaceutical, vaccine, and consumer wellness company. (Declaration of Sylvetta Harris dated April 13, 2017 ("Harris Decl.") ¶ 2, Dkt. No. 34; Pl. Dep. 19:9-18.
Plaintiff began working for GSK as a pharmaceutical sales representative in 2002. (Pl. Dep. 13:2-3, 16-3-10.)
Plaintiff's employment with GSK was governed by GSK's Code of Conduct policy, which addressed conflicts of interest and stated, in relevant part:
(Harris Decl., Ex. A, at 9.) GSK's Code of Conduct Policy also noted that any failure to comply with its provisions will subject an employee "to disciplinary action up to and including termination from employment." (
In July 2013, as part of a corporate restructuring, Plaintiff began reporting to District Sales Manager Lauren Phillips ("Phillips"). (Pl. Dep. 18:14-23; Ranjo Decl., Ex. B ("Phillips Dep."), at 14:4-7.) While reporting to Phillips, Plaintiff worked in GSK's pulmonary and primary care pharmaceuticals line of business. (Pl. Dep. 20:20-22:3.) Plaintiff's job responsibilities included calling healthcare providers within her geographic territory, planning and recording sales calls, reporting expenses, and studying for tests necessary to promote the products to which she was assigned. (Pl. Dep. 29:12-32:9.)
Plaintiff was assigned the Middletown territory, which covered areas of Orange County, New York, and included the towns of Middletown, Goshen, Fishkill, Yorktown, Warwick, and Port Jervis. (Pl. Dep. 22:4-25; Phillips Dep. 50:10-12.) Plaintiff shared responsibility for the Middletown territory with her sales partner, Ife-Marie LaFontant ("LaFontant"). (Pl. Dep. 25:14-26:16.)
Prior to 2009, Plaintiff obtained a certification to work as a Corporate Wellness coach and, by 2010, had started her own health and wellness business, New Normal Lifestyles ("NNL"). (Pl. Dep. 35:2-36:18, 38:2-16.) Between 2010 and 2014, Plaintiff worked with clients on nutrition and other issues related to personal health and wellness independent of her sales work with GSK. (Pl. Dep. 36:24-38:12.) Sometime in either 2011 or 2012, Plaintiff received a certification in nutrition. (Pl. Dep. 10:17-12:24.)
Through her NNL business, Plaintiff also provided educational services related to health and wellness to colleges, including Bard College and Empire State College. (Pl. Dep. 37:7-9, 38:17-22, 58:3-6, 75:4-13.) For example, from July to December 2013, Plaintiff taught a weekly health and nutrition Wellness Course at Bard College that started at noon on Wednesdays and lasted one hour. (Pl. Dep. 61:13-64:12, 67:8-16, 72:6-25.) Bard College was located outside of Plaintiff's GSK territory, and such classes caused Plaintiff to be outside her assigned GSK territory and performing her assigned GSK work for between one to two hours each session, according to Plaintiff, (Pl. Dep. 66:6-8), or greater than two hours, according to Defendants, (Pl. Dep. 63:4-65:16, 66:2-13). The parties do not dispute that during Plaintiff's eighteen weeks of teaching at Bard College, Plaintiff sent and received emails related to her NNL business and may have prepared for teaching the Bard College classes during her GSK working hours. (Pl. Dep. 74:7-23, 84:5-85:87:24.) After completing two nine-week sessions, Plaintiff chose to stop teaching the Wellness Course. (Pl. Dep. 75:13-78:25.)
Plaintiff also lectured on nutrition at Empire State College on at least one occasion in April 2014. (Pl. Dep. 58:3-59:5-18.) The parties dispute the degree to which Plaintiff prepared for her lecture during work hours prior to the class, and Plaintiff does not recall when she prepared. (
Plaintiff operated a blog to promote her NNL business, on which she provided advice on health issues, including eating properly, stress management, and general wellness tips. (Pl. Dep. at 40:18-43:6, 45:16-21, 48:23-49:8.) Between 2010 and 2014, Plaintiff updated the NNL blog several times a month, although the parties contest precisely how often Plaintiff generated new content and how much time, if any, was spent updating the blog during Plaintiff's regular GSK working hours. (Pl. Dep. 42:10-43:25.) Plaintiff also discussed NNL with GSK customers during her sales calls. (Pl. Dep. 55:14-57:10.)
On January 16, 2014, Plaintiff published a book related to her NNL business entitled "8 Weeks to Your New Normal Lifestyle." (Pl. Dep. 46:16-18, 49:9-50:12.) Plaintiff's book provided readers with a journal for logging their weekly food habits and "new healthy habit[s]" they could incorporate into their meal plans. (Pl. Dep. 50:13-25.) Plaintiff wrote the book herself over the course of about one year, starting in early 2013. (Pl. Dep. 51:13-20.) Plaintiff promoted her book on social media, including Facebook, while waiting to see physicians during her assigned GSK sales calls. (Pl. Dep. 53:7-17.)
In March 2014, Plaintiff began working as an independent contractor for AdvoCare International, L.P. ("AdvoCare"), a nutrition and supplement company that promoted individual health and wellness. (Pl. Dep. 171:2-17 3:10, 174:22-175:12.) Plaintiff was an independent distributer of AdvoCare products in four general areas: weight management, performance, energy, and overall wellness. (Pl. Dep. 174:14-23; 17 9:14-182:11.) Plaintiff sold AdvoCare products from March 2014 throughout the remainder of her employment with GSK. (
Plaintiff had her own webpage as part of AdvoCare's website, on which she wrote, in relevant part:
(Pl. Dep., Ex. 10.) Plaintiff has stated that she had been working towards becoming an AdvoCare "Advisor" for several months prior to her GSK termination. (Pl. Dep. 178:2-17 9:18.)
Plaintiff discussed "everything [she] was doing" with NNL and AdvoCare with LaFontant. (Pl. Dep. 44:9-45:4, 46:4-11, 47:2-9.) Plaintiff also discussed NNL with Ken Rooney, another GSK sales representative. (Pl. Dep. 47:13-48:22, 182:16-184:25.) Plaintiff never disclosed her NNL business or AdvoCare position to Phillips or any other member of GSK management before taking medical leave. (Pl. Dep. 47:13-48:22, 175:25-17 6:7.)
On April 30, 2014, Plaintiff visited her primary care physician, Dr. Anita V. Pavels ("Pavels") after experiencing what she described as "stress related heart palp[itations], dizziness, sleep problems" and shortness of breath. (Ranjo Decl., Ex. C; see Pl. Dep. 128:22-129:17.) Pavels referred Plaintiff to a cardiovascular specialist to undergo testing of her heart, which ultimately revealed no heart-related issues and concluded a diagnosis of stress and anxiety. (
On or around May 12, 2014, Plaintiff arrived approximately forty-five minutes late to a physician call where she was supposed to meet Phillips. (Pl. Dep. 137:12-138:13; Phillips Dep. 32:20-33:11.) According to Defendants, Plaintiff began crying and explained to Phillips that she was experiencing stress related to her job; Phillips advised Plaintiff that if Plaintiff was unable to conduct the sales call, she should go home for the day and consider seeking help from a doctor or GSK's Employee Health Management. (Pl. Dep. 138:15-139:22; Phillips Dep. 31:23-32:11.) Plaintiff contends that, upon arriving to the call, Phillips yelled at Plaintiff for being late, which caused Plaintiff to cry. (Pl. Dep. 138: 15.) Phillips stated she did not understand why Plaintiff was behaving that way, to which Plaintiff explained her stress levels were very high; Phillips responded: "I don't understand. High performing reps find workarounds. I can't get why you can't do this," to which Plaintiff said she needed Phillips to "understand and to help [her]." (Pl. Dep. 136:3-2, 138:15-139:22.)
On or around May 14, 2014, Plaintiff contacted GSK's Human Resources Department and requested medical leave because "she needed . . . to take some time for herself" due to work-related stress. (Pl. Dep. 140:10-20.) Plaintiff also submitted a Short-Term Disability Benefit Statement from Pavels, on which Pavels wrote that Plaintiff's "current physical limitations and impairments" were that Plaintiff was "unable to perform [her] job duties." (Harris Decl., Ex. B.) GSK granted Plaintiff leave under the FMLA on June 2, 2014, effective May 19, 2014. (Harris Decl. ¶ 14.)
Shortly after learning that Plaintiff would be taking FMLA leave, Phillips sent an email to GSK's Human Resources and wrote that, "When it rains, it pours." (Boland Aff., Ex. H.) Defendants note that Phillips was referring in that email to a different employee who had received negative performance reviews at the same time Plaintiff went out on leave and that, "everything was happening at one time." (Phillips Dep. 30:3-31:17.) In June 2014, two of Phillips's other sales representatives also were out on medical leave; both are still employed by GSK. (Phillips Dep. 51:13-52:2.)
On or around June 3, 2014, LaFontant informed Phillips that Plaintiff had been operating her own health and wellness businesses, NNL. (Phillips Dep. 48:25-49:4, 40:22-41:24.) LaFontant also told Phillips that Plaintiff had taught classes at a local college during GSK work hours. (Phillips Dep. 41:11-24.) Phillips reported this information to her manager, Regional Vice President of Sales Sean McLoughlin, who advised Phillips to contact GSK's Integrity Hotline. (
On June 4, 2014, Phillips called the Integrity Hotline and repeated the information she had learned from LaFontant. (Phillips Dep. 40:22-42:7.) Defendants contend that Phillips suspected that Plaintiff's side business could present a conflict of interest with her job for GSK, particularly given that Plaintiff was operating NNL during GSK work hours. (Phillips Dep. 41:17-42:4.) Plaintiff contends that Phillips reported Plaintiff "[bjecause [Plaintiff] was employed by GSK to perform her role as a sales representative and not have other jobs while doing so. It seems wrong." (Phillips Dep. 41:25-43:4.) The matter was referred to Kevin Ryan ("Ryan"), Director of GSK's Corporate Investigations Team. (Harris Decl. ¶ 5.)
On June 12, 2014, Plaintiff began psychiatric treatment with Dr. William H. Hartwig ("Hartwig"), a clinical psychologist. (Ranjo Decl., Ex. E.) Plaintiff saw Hartwig approximately once per week during her leave, during which time Hartwig did not diagnose Plaintiff with any mental or physical conditions, other than noting at times that she had problems with "anxiety," "depression," and "compulsive behavior." (Pl. Dep. 145:24-150:25, 155:8-16;
Just before returning from medical leave, Plaintiff tried out for the television show "Survivor" at Mohegan Sun in Connecticut. (Pl. Dep. 97:24-100:3.) Plaintiff did not inform anyone at GSK that she tried out for the show. (Pl. Dep. 100:24-101:5.) Plaintiff states that she tried out based on encouragement of her therapist who told Plaintiff to "do things that were fun." (Pl. Dep. 100:8-12.)
On August 20, 2014, Plaintiff requested a transition plan in advance for her return to work. (Pl. Dep. 116:12-117:8; Phillips Dep. 42:18-44:2.) Phillips provided the requested plan and a "to do" list for Plaintiff upon her return, both actions Phillips performed for subordinates returning from any type of leave of absence. (Phillips Dep. 42:14-43:7, 45:8-46:4.) Aside from Phillips, the only other contact Plaintiff had with GSK during her leave was with a third-party leave administrator. (Pl. Dep. 115:11-21.)
On August 25, 2014, Plaintiff returned from her FMLA leave without any restrictions per Hartwig's direction. (Pl. Dep. 159:9-10.) After returning to work, Plaintiff received treatment from Hartwig about once every one or two months and stopped seeing him altogether at some point in 2014, which Plaintiff claims was due to her loss of health insurance coverage following her termination from GSK. (Pl. Dep. 159:8-160:25, 161:14-23.) Plaintiff also claims that upon returning to work, Phillips began micromanaging Plaintiff's day, requiring Plaintiff to detail her activities, as well as take assessment exams demonstrating knowledge of various new products which Plaintiff states were scheduled at inconvenient times. (Pl. Dep. 109:4-17, 118:19-119:24; BolandAff., Ex. M.)
On September 10, 2014, Ryan and another member of GSK's Corporate Investigations Team, Benjamin Byrne, interviewed Plaintiff as part of their investigation. (Pl. Dep. 89:24-90:9, 94:15-95:3.) During Plaintiff's interview, she provided, in relevant part, the following responses:
On September 12, 2014, Ryan advised Plaintiff by email that his investigation was complete and provided her with a copy of the transcript from his September 10, 2014, interview of her. (Pl. Dep. 94:15-96:15.) Ryan further advised that while "the investigation process [was] completed[,] [his] report [would] be reviewed by the appropriate level of HR management to determine final disposition." (
On September 15, 2014, Ryan issued a final report. (
Subsequent to that review, GSK Human Resources Manager Sylvetta Harris ("Harris") contacted Bard College and confirmed that Plaintiff had taught there for about one to one-and-onehalf hours every Wednesday from September to December 2013. (Harris Decl., Ex. D.) Around this time, Defendants also claim that Plaintiff threatened Phillips, which resulted in Phillips refusing to go on a ride-along with Plaintiff, a comment that Plaintiff denies making. (
On September, 17, 2014, Plaintiff called GSK's Employee Relations Center to complain that Phillips had been treating her harshly because she had taken medical leave. (Pl. Dep. 121:4-122:25.) Plaintiff complained that Phillips had been more critical of her work and had been managing her more closely since returning from leave, including making a comment about how Plaintiff was "in second gear" since her return and canceling a ride-along. (Pl. Dep. 122:7-25, 125:17-128.) At the time, the parties dispute whether Plaintiff believed that Phillips initiated the compliance investigation into Plaintiff's NNL business. (Pl. Dep. 89:11-19.) Harris investigated Plaintiff's complaint and, after interviewing Phillips, found no evidence tc support a conclusion that Plaintiff was being harassed by her manager. (Harris Decl. ¶ 7.)
On October 21, 2014, Ryan's final report was submitted to GSK's Employee Relations Advisory Team ("ERAT") for review in accordance with GSK procedures. (Harris Decl. ¶ 8.) The ERAT was comprised of members of GSK's Employee Relations Department, among others, and did not include Phillips or any other managers with direct supervisory authority over Plaintiff. (
After reviewing Ryan's final report and the outcome of Harris's interview of Bard College, the ERAT concluded that Plaintiff had violated GSK policy prohibiting actual or potential conflicts of interest and recommended that Plaintiff's employment be terminated. (Harris Decl. ¶ 10.)
On or about October 22, 2014, Harris relayed the ERAT's recommendation to Phillips and McLoughlin who accepted the recommendation and, on December 5, 2015, communicated the termination decision to Plaintiff in person. (Harris Decl. ¶¶ 11-12; Pl. Dep. 102:22-105:9.)
Summary judgment is appropriate only where "there is no genuine issue as to any material fact and . . . the moving party is entitled to a judgment as a matter of law." Fed. R. Civ. P. 56(c). A dispute is "genuine" if "the evidence is such that a reasonable jury could return a verdict for the nonmoving party."
Courts must exercise "an extra measure of caution" in determining whether to grant summary judgment in employment discrimination cases "because direct evidence of discriminatory intent is rare and such intent often must be inferred from circumstantial evidence. . . ."
Plaintiff has several claims under her Amended Complaint which remain to be considered on Defendants' motion for summary judgment: Plaintiff's claim of retaliation for taking FMLA leave in violations of the statute (Count I), and Plaintiff's claims of discriminatory termination based on a known or perceived disability in violation of the NYSHRL (Counts II and III). (
Under the FMLA, it is unlawful for an "employer to interfere with, restrain, or deny the exercise of or the attempt to exercise," FMLA rights. 29 U.S.C. § 2615(a)(1). Claims of retaliation, such as made by Plaintiff here, are analyzed under the burden-shifting framework laid out in
If a plaintiff makes out a prima facie case, the burden shifts to the defendant "to articulate some legitimate, nondiscriminatory reason" for the adverse actions.
If a nondiscriminatory explanation for the adverse action is established, "the burden shifts back to the plaintiff to demonstrate by competent evidence that the legitimate reasons offered by the defendant were not its true reasons, but were a pretext for discrimination."
Plaintiff argues retaliation by Defendants following her return from FMLA leave by pointing to several actions taken by Phillips, including: instructing Plaintiff to complete a "to do list; requiring Plaintiff to submit weekly reports; providing Plaintiff with a transition plan; sending her curt emails; accusing her of being "stuck in second gear;" and cancelling a previously scheduled ride-along. (
The Second Circuit has held that, "[f]or purposes of the FMLA's anti-retaliation provision, a materially adverse action is any action by the employer that is likely to dissuade a reasonable worker in the plaintiff's position from exercising his legal rights."
The majority of Plaintiff's allegations, aside from her termination, do not constitute adverse employment actions. Plaintiff has claimed, inter alia, that Phillips sent Plaintiff rude emails, complained about Plaintiff's work performance, micromanaged Plaintiff and Plaintiff's schedule, required Plaintiff to engage in product knowledge assessments at inconvenient times, and canceled ride-alongs with Plaintiff. Such actions are not so harmful or materially adverse as to "well dissuade a reasonable worker from making or supporting a charge of discrimination."
Even if Plaintiff had shown adverse actions other than termination, the circumstances alleged do not give rise to an inference of retaliatory intent. An inference of retaliation can be established: "(i) indirectly through a showing that the protected activity was followed closely by discriminatory treatment, commonly known as temporal proximity;' (ii) indirectly through other evidence such as disparate treatment of similarly-situated employees; or (iii) directly through a showing of evidence of retaliatory animus toward plaintiff by defendant."
To start, as described above, the gravamen of Plaintiff's allegations of discriminatory actions reside in the aftermath of Plaintiff's return from FMLA leave in August 2014, but the many months between those actions and her eventual termination in December 2014 "militates against an inference of causation."
Plaintiff argues that a temporal connection exists by looking to the time between her taking FMLA leave and Phillips informing GSK of Plaintiff's side businesses. In certain circumstances, actions taken around the time of an initiation of an investigation that ultimately results in termination can create such an inference.
Viewed in the light most favorable to Plaintiff, no favorable inference exists here. The undisputed facts show that Plaintiff requested FMLA leave, which GSK granted; around the same time, Phillips learned that Plaintiff had side businesses, which she promptly reported to GSK. Plaintiff has put forward no evidence, other than an email from Phillips complaining about the number of GSK employees taking leave and commenting that "when it rains it pours," to suggest intent, and nothing but her own "speculation" that that LaFontant and Phillips were part of a broader plan to have Plaintiff terminated.
Plaintiff also has not provided evidence of disparate treatment. In her motion papers, Plaintiff puts forward as proof two other GSK sales representatives that had side businesses who were not terminated: one who was "a real estate agent" and one who "was also an independent contractor for Advocare." (PL's Opp. at 16;
In sum, Plaintiff has not made a prima facie showing. Nevertheless, out of an abundance of caution, a review of Defendants' justification for Plaintiff's termination and possible pretext will also be performed.
Assuming, arguendo, that Plaintiff has met her burden to make out a prima facie case, the next stage to consider is whether Defendants have proffered a legitimate, nondiscriminatory reason for Plaintiff's termination. In response, Defendants put forward that they terminated Plaintiff's employment for her violation of GSK's corporate policy prohibiting "actual or potential conflicts of interest." (Harris Decl., Ex. A, at 9.) Based on the evidence presented with regard to Plaintiff's health and nutrition side businesses in the context of GSK conflict of interest policies, this argument, "taken as true, would permit the conclusion that there was a nondiscriminatory reason" for their action.
To rebut the legitimate reasons for her discharge, Plaintiff must, without the benefit of any presumptions, show that a reasonable jury could conclude by a preponderance of the evidence that her "disability was at least motivating factor' for the adverse employment action."
Plaintiff supports her claim of pretext with similar evidence that supported her claim for an inference of discrimination, principally pointing to the timing of Phillips' request to start a GSK investigation relative to Plaintiff taking FMLA leave and Phillips comments to Plaintiff upon Plaintiff's return.
Undergirding each of Plaintiff's contentions is the undisputed fact that Plaintiff operated a health and nutrition business on the side while a pharmaceutical sales representative of GSK. After an investigation, performed by GSK's Corporate Investigations Team and ERAT, GSK determined Plaintiff was in violation of GSK's corporate policies that prohibit employees from actual or potential conflicts of interest. When evaluating Plaintiff's rebuttal in the context of this background, "it is not the function of a fact-finder to second-guess business decisions."
First, Plaintiff's claims about her high work performance and purported ability to balance her side businesses and other GSK work are the kinds of "subjective view[s]" that do "not create a genuine issue of material fact."
Second, Phillips comments about Phillips, both to Plaintiff and to GSK employees, do not establish Plaintiff's claims. As already noted, many of Phillips's actions, such as her email comment that "when it rains it pours" and comments and actions about Plaintiff's work performance upon Plaintiff's return from FMLA leave either have reasonable non-retaliatory explanations or, even if viewed in the most favorable light to Plaintiff, amount only to the kinds of unpleasant yet unavoidable interactions endemic to professional life and, without additional, more concrete evidence, "shed[ ] no light on the ultimate decision to terminate [plaintiff]."
Thirdly, Plaintiff's argument as to the temporality between Phillips' report to GSK and Plaintiff's FMLA leave cannot support Plaintiff's retaliation claim. No evidence, other than Plaintiff's conjectures, suggests that Phillips, in reporting Plaintiff to GSK, was motivated by anything other than learning for the first time about Plaintiff's side businesses back in June 2014. With no additional evidence, "[t]he timing of events alone, even if sufficient to meet the plaintiff's prima facie burden, cannot defeat summary judgment in the face of defendant's proffered legitimate reason."
In sum, as Plaintiff has failed both to establish either a prima facie case of retaliation or that her taking of FMLA was a motivating factor in Defendants' termination of her employment in opposition to Defendants' proffered non-retaliatory explanation, Defendants' motion for summary judgment as to the Amended Complaint's Count I is granted.
Plaintiff also contends that Defendants discriminated against her on the basis of a disability or perceived disability in violation of the NYSHRL. Analysis of claims made under the NYCHRL requires a separate and independent analysis from any federal and state law claims, and is construed "broadly in favor of discrimination plaintiffs, to the extent that such a construction is reasonably possible."
Under New York State law, a legally recognized disability requires showing:
N. Y. EXEC. LAW § 292 (21) .
To obtain summary judgment on a NYCHRL claim, a defendant must show that "no jury could find defendant liable under any of the evidentiary routes: under the
Plaintiff argues that she was diagnosed by Hartwig with anxiety, depression, and compulsive disorder, establishing an actual disability, and that she suffered a breakdown in front of Phillips in addition to having discussions with co-workers about her work-induced stress, which would cause Defendants to perceive Plaintiff as having a disability.
First, the proffered records from Hartwig are "Progress Reports" that merely indicate observations of Hartwig and do not clearly establish any diagnoses made. (
As to the evidence put forward by Plaintiff about her conversations with other GSK employees and her singular breakdown in front of Phillips, such examples only provide Plaintiff the fuel for conjecture that Defendants might have perceived Plaintiff as possessing a disability rather than demonstrating affirmatively that Defendant did have this perception. Conjecture is not enough to sustain a NYSHRL discrimination claim; "[t]o establish discrimination based on perceived disability, a plaintiff must
Lastly, for similar reasons described above, Plaintiff has not established a prima facie showing that the termination of her employment occurred under circumstances giving rise to an inference of discrimination.
As Plaintiff has neither established that she possessed a disability protected by the NYSHRL nor that the circumstances under which she was terminated give rise to an inference of disability discrimination, Defendants' motion for summary judgment as to the Amended Complaint's Count II and III is granted.
For the foregoing reasons, Defendants' motion for summary judgment is granted.
It is so ordered.